Advanced company searchLink opens in new window

SUNDARA PHARMACEUTICALS LTD

Company number 11636445

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
31 Oct 2023 CS01 Confirmation statement made on 14 October 2023 with no updates
20 Jun 2023 AA Total exemption full accounts made up to 31 December 2022
16 May 2023 TM01 Termination of appointment of Paul Watson as a director on 15 May 2023
14 Oct 2022 CS01 Confirmation statement made on 14 October 2022 with no updates
29 Jul 2022 AA Total exemption full accounts made up to 31 December 2021
11 Nov 2021 PSC04 Change of details for Dr Samer Taslaq as a person with significant control on 8 December 2020
03 Nov 2021 CS01 Confirmation statement made on 22 October 2021 with updates
25 Oct 2021 PSC01 Notification of Samer Taslaq as a person with significant control on 8 December 2020
22 Sep 2021 AA Total exemption full accounts made up to 31 December 2020
25 Jun 2021 AA01 Previous accounting period extended from 31 October 2020 to 31 December 2020
21 Jun 2021 PSC07 Cessation of Leslie Anderson as a person with significant control on 8 December 2020
16 Dec 2020 SH01 Statement of capital following an allotment of shares on 8 December 2020
  • GBP 83.48
16 Dec 2020 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
16 Dec 2020 AP01 Appointment of Dr Samer Taslaq as a director on 16 December 2020
05 Nov 2020 CS01 Confirmation statement made on 22 October 2020 with no updates
09 Jul 2020 AA Accounts for a dormant company made up to 31 October 2019
31 Oct 2019 CS01 Confirmation statement made on 22 October 2019 with no updates
23 Oct 2018 NEWINC Incorporation
Statement of capital on 2018-10-23
  • GBP 10